Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangsheng Du

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 26, 2022
Aluminum nanoparticles deliver a dual-epitope peptide for enhanced anti-tumor immunotherapyShuting Bai, Hao Jiang, Yuanshuai Song, et al.
Acta Pharmaceutica Sinica. B|September 1, 2023
An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancerYunting Zhang, Min Jiang, Guangsheng Du, et al.
Science Advances|June 30, 2020
The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiencyXiaoyu Hong, Xiaofang Zhong, Guangsheng Du, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 2022
Smart combination of aluminum hydroxide and MF59 to induce strong cellular immune responsesZhengjun Chen, Xinyan Hao, Hairui Wang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 14, 2025
Application of in-silico approaches in subunit vaccines: Overcoming the challenges of antigen and adjuvant developmentXue Tang, Jiayin Deng, Chunting He, et al.
Gut|February 28, 2024
Recurrent intestinal ulcers and perforations complicated with pigmentationJunfeng Guo, Linxi Su, Guangsheng Du, et al.
Frontiers in Immunology|September 5, 2022
Identification and verification of YBX3 and its regulatory gene HEIH as an oncogenic system: A multidimensional analysis in colon cancerYiming Sun, Zhixi Li, Wensheng Wang, et al.
International Journal of Molecular Medicine|December 12, 2025
Selective autophagic degradation of glycolytic activator PFKFB3 contributes to maintaining intestinal epithelial barrier in inflammatory bowel diseaseYiyang Pan, Feng Yang, Liucan Wang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2024
Transdermally delivered tolerogenic nanoparticles induced effective immune tolerance for asthma treatmentJiaxuan Zhao, Penghui He, Min Jiang, et al.
Mediators of Inflammation|May 8, 2020
Decreased Plasma Maresin 1 Concentration Is Associated with Diabetic Foot UlcerTian Miao, Bangliang Huang, Niexia He, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 26, 2022
Aluminum nanoparticles deliver a dual-epitope peptide for enhanced anti-tumor immunotherapyShuting Bai, Hao Jiang, Yuanshuai Song, et al.
Acta Pharmaceutica Sinica. B|September 1, 2023
An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancerYunting Zhang, Min Jiang, Guangsheng Du, et al.
Science Advances|June 30, 2020
The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiencyXiaoyu Hong, Xiaofang Zhong, Guangsheng Du, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 2022
Smart combination of aluminum hydroxide and MF59 to induce strong cellular immune responsesZhengjun Chen, Xinyan Hao, Hairui Wang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 14, 2025
Application of in-silico approaches in subunit vaccines: Overcoming the challenges of antigen and adjuvant developmentXue Tang, Jiayin Deng, Chunting He, et al.
Gut|February 28, 2024
Recurrent intestinal ulcers and perforations complicated with pigmentationJunfeng Guo, Linxi Su, Guangsheng Du, et al.
Frontiers in Immunology|September 5, 2022
Identification and verification of YBX3 and its regulatory gene HEIH as an oncogenic system: A multidimensional analysis in colon cancerYiming Sun, Zhixi Li, Wensheng Wang, et al.
International Journal of Molecular Medicine|December 12, 2025
Selective autophagic degradation of glycolytic activator PFKFB3 contributes to maintaining intestinal epithelial barrier in inflammatory bowel diseaseYiyang Pan, Feng Yang, Liucan Wang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2024
Transdermally delivered tolerogenic nanoparticles induced effective immune tolerance for asthma treatmentJiaxuan Zhao, Penghui He, Min Jiang, et al.
Mediators of Inflammation|May 8, 2020
Decreased Plasma Maresin 1 Concentration Is Associated with Diabetic Foot UlcerTian Miao, Bangliang Huang, Niexia He, et al.
Pageof 8